Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy
Introduction: CD105 is an angiogenic biomarker whose expression has inconsistent effects in the prognosis of GBM patients. We aimed to evaluate the prognostic impact of CD105 and proliferation index in primary and recurrent tumoral specimens of a cohort of GBM patients treated with bevacizumab upon...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/142080 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/142080 |